Clinical Trials

1 2 3 220
Number of results: 4392

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-11-14 SEA-BCMA multiple myeloma 1 Seattle Genetics (USA - WA) Cancer - Oncology
2018-11-14 PD-L1 x CD137 Bispecific DART® molecules preclinical Macrogenics (USA - MD) Cancer - Oncology
2018-11-14 PH-10 atopic dermatitis, psoriasis Provectus Pharmaceuticals (USA - TN) Autoimmune diseases - Dermatological diseases - Inflammatory diseases
2018-11-11 alirocumab (SAR236553/REGN727) patients with heterozygous familial hypercholesterolemia (heFH)
patients with primary hypercholesterolemia with elevated LDL-C
3 Sanofi (France) Regeneron Pharmaceuticals (USA - NY) Cardiovascular diseases - Genetic diseases - Rare diseases
2018-11-03 SARM1 inhibitor preclinical Disarm Therapeutics (USA - MA) Neurological diseases - Neurodegenerative diseases
2018-11-02 CV-301 in combination with durvalumab metastatic colorectal cancer, metastatic pancreatic cancer 1-2 Bavarian Nordic (Denmark) Cancer - Oncology
2018-11-01 BN-Brachyury and radiation advanced chordoma 2 Bavarian Nordic (Denmark) Cancer - Oncology - Rare diseases
2018-11-01 PCM-075 - onvansertib (1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt) acute myeloid leukemia (AML) 1b-2 Trovagene (USA - CA) Cancer - Oncology
2018-10-31 facioscapulohumeral dystrophy (FSHD) preclinical Facio Therapies (The Netherlands) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-31 Trogarzo™ (ibalizumab) HIV-1 infection 3 TaiMed Biologics (Taiwan) - Theratechnologies (Canada) Infectious diseases
2018-10-29 OSE-127 (Effi-7) inflammatory bowel diseases including Crohn's disease and ulcerative colitis preclinical OSE Immunotherapeutics (France) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-10-29 ALKS 5461 major depressive disorder (MDD) 3 Alkermes (Ireland) CNS diseases - Mental diseases
2018-10-29 faricimab (RG7716 - RO6867461) neovascular wet age-related macular degeneration (AMD) 2 Roche (Switzerland Ophtalmological diseases
2018-10-29 brolucizumab - RTH258 neovascular wet age-related macular degeneration (AMD) 3 Alcon (USA -TX), a Novartis subsidiary (Switzerland) Ophtalmological diseases
2018-10-29 daratumumab in combination with lenalidomide and dexamethasone front line multiple myeloma 3 Janssen Biotech - J&J (USA) Genmab (Denmark) Cancer - Oncology - Rare diseases
2018-10-26 sparsentan (RE-021) focal segmental glomerulosclerosis (FSGS) 2 Retrophin (USA - CA) Rare diseases - Kidney diseases - Renal diseases
2018-10-23 Aimovig™ - AMG 334 (erenumab) migraine 3b Amgen (USA - CA) Novartis (Switzerland) CNS diseases
2018-10-21 LOXO- 101 (larotrectinib - (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate pediatric patients with advanced solid or primary central nervous system tumors 1-2 Loxo Oncology (USA - CT) Cancer - Oncology
2018-10-19 apceth-201 acute graft-versus-host disease (aGvHD) preclinical apceth (Germany) Transplantation
2018-10-18 GS010- adeno-associated viral vector containing the human NADH dehydrogenase 4 gene Leber’s hereditary optic neuropathy (LHON) 3 Gensight Biologics (France) Ophtalmological diseases - Genetic diseases - Rare diseases